Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VAR2 PHARMACEUTICALS ApS
APS
Active
Advertising protection
CVR 34621942
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
11 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
VAR2 PHARMACEUTICALS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-5M
-4M
2021
-6M
2022
-22M
2023
-23M
2024
-22M
2025
EBITDA
DKK millions
0M
-9M
-18M
-27M
-36M
-8M
2021
-9M
-12%
2022
-26M
-189%
2023
-29M
-12%
2024
-26M
+10%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-4.433
-6.358
-22.300
-22.698
-21.739
Staff expenses
-3.119
-2.789
-3.274
-5.859
-4.613
EBITDA
-7.552
-9.147
-25.574
-28.557
-26.352
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-7.552
-9.147
-25.574
-28.557
-26.352
Net financials
79
159
1.545
2.327
1.989
Profit before tax
-7.474
-8.988
-24.029
-26.230
-24.363
Tax
-1.569
-2.183
-4.910
-5.224
-4.637
Net profit
-5.905
-6.805
-19.119
-21.006
-19.727
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
38.461
70.168
59.345
66.702
85.739
Equity
36.995
67.385
48.266
64.456
82.032
Long-term debt
290
290
290
319
331
Short-term debt
1.176
2.493
10.789
1.927
3.376
Total debt
1.466
2.783
11.078
2.246
3.707
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2635224900.0%
This company
2021
2025
Equity ratio
95.7%
This company
38.2%
Market median
+151% vs market
2021
2025
Return on equity
-24.0%
This company
18.4%
Market median
-230% vs market
2021
2025
Net profit margin (of gross profit)
-1972650800.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.25×
This company
2021
2025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on VAR2 PHARMACEUTICALS ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
